Sotalol 160 mg Tablets

Sotalol 160 mg Tablets
Product Description

Rusan Pharma Ltd offers a wide range of tablets which includes sotalol 160 mg tablets. Package size/ Form: N.28 tablet. Contact us for more information.

Rusan Pharma Ltd

  • IN
  • 2015
    On CPHI since
  • 2
    Certificates
  • 500 - 999
    Employees
Company types
Manufacturer/Innovator
Pharmaceutical company
Primary activities
API Producer
Pharmaceutical Company (innovator finished products)
Specifications
  • Details
    Generic name and strength: sotalol 160 mg tablets.

Rusan Pharma Ltd

  • IN
  • 2015
    On CPHI since
  • 2
    Certificates
  • 500 - 999
    Employees
Company types
Manufacturer/Innovator
Pharmaceutical company
Primary activities
API Producer
Pharmaceutical Company (innovator finished products)

More Products from Rusan Pharma Ltd (44)

  • Sangesic Tablet & Patch

    Product Sangesic Tablet & Patch

    Sangesic  Tablet :-1. Faster onset of action 
    2. Better patient Compliance 
    3. Long duration of action ( 6hrs tp 12 hrs.) 
    4. Effective in moderate to severe pain management

    Sangesic  Patch:- 
    1. Well tolerated 
    2. Continouse pain relie...
  • Sangesic Tablet & Patch

    Product Sangesic Tablet & Patch

    Rusan Pharma Ltd offers a wide range of tablets which includes diazepam 5 mg tablets. Package size/ Form: N.28/N.100 tablet. Contact us for more information.
  • Serulan Injection 2 ml.

    Product Serulan Injection 2 ml.

    Rusan Pharma Ltd offers a wide range of small volume parenterals which includes serulan injection 2 ml. Package size/ Form: N.50 injection. Contact us for more information.
  • Serulan Tablet

    Product Serulan Tablet

    Rusan Pharma Ltd offers a wide range of tablets which includes serulan tablet. Package size/ Form: N.100 tablet. Contact us for more information.
  • Silvacin Cream 15 gm.

    Product Silvacin Cream 15 gm.

    Rusan Pharma Ltd offers a wide range of creams/ gels & ointments which includes silvacin cream 15 gm.=. Package size/ Form: N.1 tube. Contact us for more information.
  • Silvacin Cream 30 gm.

    Product Silvacin Cream 30 gm.

    Rusan Pharma Ltd offers a wide range of creams/ gels & ointments which includes silvacin cream 30 gm. Package size/ Form: N.1 tube. Contact us for more information.
  • Sotalol 40 mg Tablets

    Product Sotalol 40 mg Tablets

    Rusan Pharma Ltd offers a wide range of tablets which includes sotalol 40 mg tablets. Package size/ Form: N.28 tablet. Contact us for more information.
  • Sotalol 80 mg Tablet

    Product Sotalol 80 mg Tablet

    Rusan Pharma Ltd offers a wide range of tablets which includes sotalol 80 mg tablet. Package size/ Form: N.28 tablet. Contact us for more information.
  • Spasmogard Injection 5 ml.

    Product Spasmogard Injection 5 ml.

    Rusan Pharma Ltd offers a wide range of small volume parenterals which includes spasmogard injection 5 ml. Package size/ Form: N.5 injection. Contact us for more information.
  • Spasmogard Tablet

    Product Spasmogard Tablet

    Rusan Pharma Ltd offers a wide range of tablets which includes spasmogard tablet. Package size/ Form: N.100 tablet. Contact us for more information.
  • Sulphasalazine Tablets

    Product Sulphasalazine Tablets

    Rusan Pharma Ltd offers a wide range of tablets which includes sulphasalazine tablets. Package size/ Form: tablet. Contact us for more information.
  • Tamoxifen Citrate Tablet USP

    Product Tamoxifen Citrate Tablet USP

    Rusan Pharma Ltd offers a wide range of tablets which includes tamoxifen citrate tablet USP. Package size/ Form: N.60 tablet. Contact us for more information.

Rusan Pharma Ltd resources (2)

  • News Rusan Pharma’s API Plant in Ankleshwar (India) Receives USFDA GMP Approval

    RUSAN PHARMA PRIVATE LIMITED, an Indian pharmaceutical company specializing in addiction treatment and pain management, announced that its Active Pharmaceutical Ingredient (API) facility in Ankleshwar, Gujarat, received Good Manufacturing Practice (GMP) approval from the USFDA on May 29, 2024, following a rigorous inspection. This approval marks a significant milestone, enabling Rusan to expand into the US API market, particularly for niche APIs like Eflornithine and Nalmefene, while planning to add more APIs to its portfolio. Rusan Pharma’s Managing Director, Dr. Kunal Saxena, emphasized the company’s commitment to quality and global expansion. The USFDA approval complements Rusan's existing GMP certifications from Health Canada, the EU, and Brazil’s ANVISA, and aligns with the company’s vision to be a leader in addiction treatment and pain management. 
  • Technical Data Commercials APIs & APIs Under Development

    Commercials APIs  & APIs Under Development